- Home
- PASG vs COSM Comparison
PASG vs COSM Comparison
Compare PASG & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PASG
- COSM
- Stock Information
- Founded
- PASG 2017
- COSM 2009
- Country
- PASG United States
- COSM United States
- Employees
- PASG N/A
- COSM N/A
- Industry
- PASG Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- PASG Health Care
- COSM Health Care
- Exchange
- PASG Nasdaq
- COSM Nasdaq
- Market Cap
- PASG 27.6M
- COSM 32.3M
- IPO Year
- PASG 2020
- COSM 2013
- Fundamental
- Price
- PASG $7.32
- COSM $0.78
- Analyst Decision
- PASG Strong Buy
- COSM
- Analyst Count
- PASG 4
- COSM 0
- Target Price
- PASG $59.25
- COSM N/A
- AVG Volume (30 Days)
- PASG 37.0K
- COSM 886.9K
- Earning Date
- PASG 11-17-2025
- COSM 11-14-2025
- Dividend Yield
- PASG N/A
- COSM N/A
- EPS Growth
- PASG N/A
- COSM N/A
- EPS
- PASG N/A
- COSM N/A
- Revenue
- PASG N/A
- COSM $55,093,442.00
- Revenue This Year
- PASG N/A
- COSM $28.14
- Revenue Next Year
- PASG N/A
- COSM N/A
- P/E Ratio
- PASG N/A
- COSM N/A
- Revenue Growth
- PASG N/A
- COSM N/A
- 52 Week Low
- PASG $5.12
- COSM $0.28
- 52 Week High
- PASG $26.60
- COSM $1.32
- Technical
- Relative Strength Index (RSI)
- PASG 43.77
- COSM 33.13
- Support Level
- PASG $6.82
- COSM $0.77
- Resistance Level
- PASG $7.90
- COSM $1.04
- Average True Range (ATR)
- PASG 0.64
- COSM 0.10
- MACD
- PASG -0.13
- COSM -0.04
- Stochastic Oscillator
- PASG 23.04
- COSM 1.20
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.